Benyam Muluneh, Pharm.D.

Benyam Muluneh, PharmD., BCOP, CPP received his doctor of pharmacy at the UNC Eshelman School of Pharmacy and completed both PGY1 (Pharmacy Practice) and PGY2 (Hematology/Oncology) residencies at UNC Medical Center.  After residency, he practiced full time as a clinical pharmacist practitioner where he and his team established a pharmacist-led oral chemotherapy program which was designated with an ASHP Best Practice Award in 2015. Muluneh has since co-authored the 2018 Hematology/Oncology Pharmacist Association (HOPA) Best Practices for the Management of Oral Oncolytic Therapy and the 2022 Oncology Nursing Society’s Guidelines to Support Patient Adherence to Oral Anticancer Medications.

Muluneh joined DPET in July 2019 as a full time assistant professor. His ongoing research endeavors include: 1) Develop strategies to improve medication adherence in clinical practice; 2) Optimize tolerability and safety of chemotherapy in cancer patients; and 3) Promote chemotherapy access and affordability to underinsured and uninsured cancer patients in the United States and beyond. He also teaches in the PharmD curriculum and has a passion for international health. He is the co-director of the UNC-Ethiopia Alliance and serves as a preceptor for one of the Global Pharmacy Scholar (GPS) experiences to Ethiopia.